PCV71 COST-EFFECTIVENESS OF EZETIMIBE/SIMVASTATIN VERSUS SIMVASTATIN- WILL THE INCREASED RISK OF CANCER MAKE EZETIMIBE/SIMVASTATIN AN INAPPROPRIATE TREATMENT CHOICE?
May 1, 2009, 00:00
10.1016/S1098-3015(10)73832-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)73832-8/fulltext
Title :
PCV71 COST-EFFECTIVENESS OF EZETIMIBE/SIMVASTATIN VERSUS SIMVASTATIN- WILL THE INCREASED RISK OF CANCER MAKE EZETIMIBE/SIMVASTATIN AN INAPPROPRIATE TREATMENT CHOICE?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73832-8&doi=10.1016/S1098-3015(10)73832-8
First page :
Section Title :
Open access? :
No
Section Order :
303